In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

Melina Awar; Eleftherios Mylonakis

doi:10.7326/J23-0039

In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

Melina Awar, Eleftherios Mylonakis

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

SOURCE CITATION: Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.

Original language	English (US)
Journal	Annals of Internal Medicine
Volume	176
Issue number	6
Early online date	Jun 6 2023
DOIs	https://doi.org/10.7326/J23-0039
State	Published - Jun 2023

Keywords

Aged
Antibodies, Viral
Humans
Respiratory Syncytial Virus Infections/prevention & control
Respiratory Syncytial Virus Vaccines
Respiratory Tract Diseases

ASJC Scopus subject areas

Internal Medicine

Divisions

Hospital Medicine
Infectious Disease

Access to Document

10.7326/J23-0039

Cite this

@article{95fb057da1814001ad8db631d1ed974d,

title = "In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease",

abstract = "SOURCE CITATION: Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.",

keywords = "Aged, Antibodies, Viral, Humans, Respiratory Syncytial Virus Infections/prevention \& control, Respiratory Syncytial Virus Vaccines, Respiratory Tract Diseases",

author = "Melina Awar and Eleftherios Mylonakis",

year = "2023",

month = jun,

doi = "10.7326/J23-0039",

language = "English (US)",

volume = "176",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "6",

}

TY - JOUR

T1 - In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

AU - Awar, Melina

AU - Mylonakis, Eleftherios

PY - 2023/6

Y1 - 2023/6

N2 - SOURCE CITATION: Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.

AB - SOURCE CITATION: Falsey AR, Williams K, Gymnopoulou E, et al; CYPRESS Investigators. Efficacy and safety of an Ad26.RSV.preF-RSV preF protein vaccine in older adults. N Engl J Med. 2023;388:609-620. 36791161.

KW - Aged

KW - Antibodies, Viral

KW - Humans

KW - Respiratory Syncytial Virus Infections/prevention & control

KW - Respiratory Syncytial Virus Vaccines

KW - Respiratory Tract Diseases

UR - https://www.scopus.com/pages/publications/85163922928

UR - https://www.scopus.com/inward/citedby.url?scp=85163922928&partnerID=8YFLogxK

U2 - 10.7326/J23-0039

DO - 10.7326/J23-0039

M3 - Article

C2 - 37276605

SN - 0003-4819

VL - 176

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 6

ER -

In older adults, an Ad26.RSV.preF-RSV preF protein vaccine reduced RSV-related lower respiratory tract disease

Abstract

Keywords

ASJC Scopus subject areas

Divisions

Access to Document

Other files and links

Fingerprint

Cite this